Malignant coronary vasospasm refractory to nitrates: Using clevidipine as an emergent coronary vasodilator

Arch Cardiol Mex. 2022 Oct 21;92(4):537-540. doi: 10.24875/ACM.21000251.
No abstract available

Publication types

  • Letter

MeSH terms

  • Coronary Angiography
  • Coronary Vasospasm* / drug therapy
  • Humans
  • Nitrates
  • Pyridines
  • Vasodilator Agents / therapeutic use

Substances

  • Nitrates
  • clevidipine
  • Vasodilator Agents
  • Pyridines